Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of…
Whats in the Cards for Viatris Stock This Q4 Earnings? VTRS Q4 results are likely to gain from new product launches in all major geographies.…
FDA restricts import of certain Viatris products due to plant violations By Investing.com FDA restricts import of certain Viatris products due to plant violations…
Theravances Q3 Loss Narrower Than Expected, Revenues Rise Y/Y TBPH beats third-quarter estimates for both sales and earnings. Increased collaboration revenues from Viatris drive year-over-year top-line performance.…
Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments We recently published a list of 8 Stocks Under $20 To Invest In Now. In this article, we are going…
Aktienmarkt: Kurs der Viatris-Aktie im Minus (10,0972 €) An der US-amerikanischen Börse notiert das Wertpapier von Viatris zur Stunde leichter. Der jüngste Kurs betrug 11,20 US-Dollar. An der…
US Biosimilar Market Research 2024-2028 Featuring Leading Players - Pfizer, Novartis, Amgen, Samsung Biologics, Celltrion, and Viatris Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "US Biosimilar Market: Insights & Forecast (2024-2028)" report has been…
Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y Theravance (TBPH) misses second-quarter estimates on both fronts. Increased collaboration revenues from Viatris drive year-over-year top-line performance.…
Global Topical Wound Agents Market Size To Exceed USD 3.7 Billion By 2033 | CAGR Of 6.89% The Global Topical Wound Agents Market Size was valued at USD 1.9 Billion in 2023 and the Global Topical Wound…
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent By Reuters Teva, Viatris win new chance to challenge J&J schizophrenia drug patent…
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris FARMINGTON HILLS, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company…
Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82% The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…
Viatris reports upbeat 2024 revenue outlook By Investing.com Viatris reports upbeat 2024 revenue outlook…